Rilzabrutinib (Wayrilz; Sanofi) may improve immune thrombocytopenia (ITP) outcomes, enable early intervention, and enhance patient quality of life.

An expert discusses how rilzabrutinib’s covalent reversible binding mechanism provides a favorable safety profile with only manageable grade 1 to 2 toxicities and no cardiovascular or bleeding ...

Overview of Platelet Aggregation Devices MarketThe global Platelet Aggregation Devices Market is valued at USD 590.65 Million in 2024 and is projected to reach a value of USD 1086 Million by 2035 at a ...

Red Sox Player Applauded for Act Towards Ryan McMahon After Tumbling Catch Sheryl Crow Reveals 1 Tip From Her Therapist That ...

Explore how regenerative medicine is transforming healing and restoration in healthcare, and discover its potential benefits ...

The Bassett Healthcare Network has announced a regenerative and non-operative therapy for muscle, joint, and tendon injuries or issues is now being offered at Cobleskill Regional Hospital.

ProMedica’s latest DAISY and ROSE award winners were praised by patients for their kindness, attentiveness and lasting impact ...

A new clinic in Cortez is offering platelet-rich plasma injections and other regenerative treatments – and says it’s trying ...

Post-CAR T infection prophylaxis should follow European Hematology Association/European Society for Blood and Marrow ...

Classical hematologist Srila Gopal, MD, tackles the unique complexities of treating and researching sickle cell disease and ...

CRYPTICS study met the primary efficacy endpoint measure, 24-hour chest tube drainage (Difference in LS Means was 142.0 mL; 95.576% confidence ...

Single dose of avigbagene parvec (FLT201) demonstrates sustained clinical benefit and favorable safety up to two years after withdrawal of prior ...